Just a question, Stuart: are you an investor in Longevinex?

---

From: Stuart Cracraft <cracraft@cox.net>
To: ForumPoint <forumpoint@googlegroups.com>; resveratrol-users@yahoogroups.com; longevinex-users@yahoogroups.com
Cc: Steve Omohundro <steveomohundro@gmail.com>
Sent: Thursday, July 9, 2009 11:20:31 PM
Subject: [resveratrol-users] [Fwd: Scientific black out of resveratrol science]



Nicholas Wade is one of the major science writers
at the New York Times.

Bill, here, is trying to knock some sense into
the media and Wade. (Wade is a smart guy, did early
interviews of Sinclair who discovered the effects,
etc.)

Well, back to another glass of red wine here....

The French are right!

--Stuart

-------- Original Message --------

Subject:	Scientific black out of resveratrol science
Date:	Thu, 09 Jul 2009 23:02:55 -0400 (EDT)
From:	BSardi@...
To:	nwade@nytimes.com

Nicholas Wade        July 10, 2009

NYTIMES

 

From: Bill Sardi, Resveratrol Partners LLC, dba LONGEVINEX®

 

The headlines of the past day involving calorie restricted monkeys and rapamycin in pursuit of strategies to prolong the human healthspan are remarkable.

 

Yet I am perplexed by statements that hail rapamycin, an immune suppressing drug, which say a relatively short course of rapamycin is able to prolong life in laboratory mice at a late-stage of life, something that calorie restriction takes a lifetime to achieve. 

 

However, when the very same university-based researchers who performed the primate studies reported in late 2008 that our proprietary matrix of small molecules (resveratrol, quercetin, IP6 rice bran) produced a profound genomic effect, far greater than calorie restriction or plain resveratrol, and produced changes at an earlier stage of life that are only seen with life-long calorie restriction, not a word was said about this by the news press. 

 

In fact, there has been a complete black-out by the research community and the news press regarding this discovery.  Since its publication in Experimental Gerontology in Sept of 2008, not one other published paper has referred to the Longevinex study.  The black-balling has been total and complete.  One wonders why?

 

It is clear that the world need not consume 1000 bottles of wine a day to achieve longevity nor does the world need to wait another ten years for confirmation.  In fact, aging populations simply don't have another decade to wait.  The International Monetary Fund said today that the burden of caring for chronically ill retirees is 10-times greater than the current economic crisis.

 

The French have far more centenarians per capita than any other developed nation, with the greatest longevity and health exhibited among those who consume just 3-5 glasses of red wine, providing just 180-300 mg of polyphenols.  Remove the alcohol and you have an anti-aging pill.  That is what Longevinex® has attempted to produce.  That is what Professor Roger Corder, author of The Red Wine Diet, attests. 

 

The majority of the science shows there is a synergistic effect exhibited with the provision of a variety of small molecules at relatively doses, as provided in Longevinex®.  The public is at risk for following irresponsible advice to consume thousands of milligrams of resveratrol, with side effects (anemia, headaches, Achilles heel soreness) now being reported among mega-dose resveratrol pill users. 

 

---

Dell Studio XPS Desktop: Save up to $400 - Limited Time Offer